About us /

Osteogene Tech Corp was created from the founders’ desire and ambition to develop solutions to confront unmet medical and dental needs beyond demographic boundaries. Here at Osteogene, we research, manufacture, and ship our products with the utmost care to ensure consistent quality.

History

Osteogene’s current mission is to clinically improve the quality of life of patients with innovative synthetic bone void filler in dental applications.

July: Establishment of Osteogene Tech Corp (President Dongwoo Sohn; Vice President Daniel S. Oh)

Osteogene Tech Corp was established under the joint efforts and shared ambitions of Dr. Dongwoo Sohn and Dr. Daniel Oh.

September: Obtained license agreement (University of Texas) for “Bi-Layered Bone-like Scaffold” invented by Danial S. Oh and Joo Ong

Patent #: US8916228B2, EP2192876B1, CA2965384A1, ES2475966T3, WO2009021209A3

May: Completion of production facility (Norwood, NJ)

May: First scaffold testing product produced

March: Submission of a trademark application to the United States Patent and Trademark Office (USPTO)

September: Issued trademark for Inroad® by USPTO

October: Completion of InRoad® preclinical and biocompatibility testing for FDA review

March: US FDA 510K clearance for the InRoad® Dental Synthetic Bone Graft (No.K202675)

Key Personnel

Daniel S. Oh, Ph.D., VP, Chief Science Officer

Experiences for Key Personnel:

Successful commercialization of bone void filler products
Successful clinical follow-up of patients up to three years
Biological Safety tests following ISO standards
Establishment, operation and management of medical device facilities
Innovative research papers published in conferences and journals
Faculty experiences in directly related field from University of Texas and Columbia University

Product /

Product Description

Granule-type synthetic bone graft
Synthesized from hydroxyapatite (HA) and β-Tricalcium Phosphate (β-TCP)
The trabecular structure conforms to natural bone structure
The porous design allows for the migration of endogenous cells to support bone growth
No risk of disease transmission or donor site morbidity due to the synthetic nature of the product

Technology /

InRoad® Dental Synthetic Bone Graft is a synthetic, semi-dense multi-porous bioceramic for bone regeneration in dental applications. Comprised of 90 ± 5% hydroxyapatite (HA) and 10 ± 5% β-Tricalcium Phosphate (β-TCP), the product has a trabecular bone structure, which consists of three major aspects of design that results in a biocompatible, osteoconductive material. Macro pores, secondary micro channels within the structures’ walls, and micropores throughout the material make it possible for bone cells to migrate into the matrices as a result of capillary suction and support new bone growth.

Note that InRoad® Dental Synthetic Bone Graft should only be used by, or under the supervision of, specialized personnel experienced in the required techniques and use of biomaterials.

Regeneration of Large Segmental Defect using Multi-Structural Scaffold in Canine Tibia

Download PDF

Bone-like Scaffold for Vertical and Horizontal Ridge Augmentation

Download PDF